Stock VTR VENTAS, INC.
Add to a list

Ventas, Inc. Share Price

Equities

VTR

US92276F1003

Specialized REITs

Market Closed - Nyse
Other stock markets
 02:30:02 07/02/2026 am IST 		5-day change 1st Jan Change
82.55 USD +3.39% Intraday chart for Ventas, Inc. +6.28% +6.68%
06/02 Ventas, Inc., Q4 2025 Earnings Call, Feb 06, 2026
06/02 BNP Paribas Adjusts Price Target on Ventas to $87 From $80, Maintains Outperform Rating MT

Valuation: Ventas, Inc.

Capitalization 3.92TCr 3.32TCr 3.04TCr 2.88TCr 5.35TCr 3,55200Cr 5.59TCr 35TCr 14TCr 1,71000Cr 15TCr 14TCr 6,15600Cr P/E ratio 2026 *
128x
P/E ratio 2027 * 78.1x
Enterprise value 5.07TCr 4.29TCr 3.93TCr 3.72TCr 6.91TCr 4,59000Cr 7.23TCr 46TCr 18TCr 2,21000Cr 19TCr 19TCr 7,95400Cr EV / Sales 2026 *
7.67x
EV / Sales 2027 * 6.76x
Free-Float
95.41%
Yield 2026 *
2.48%
Yield 2027 * 2.65%
More valuation ratios * Estimated data

Chart: Ventas, Inc.

Dynamic Chart

Latest news: Ventas, Inc.

06/02 Ventas, Inc., Q4 2025 Earnings Call, Feb 06, 2026
06/02 BNP Paribas Adjusts Price Target on Ventas to $87 From $80, Maintains Outperform Rating MT
06/02 Ventas Q4 Normalized FFO, Revenue Rise; 2026 FFO Guidance Set MT
06/02 Earnings Flash (VTR) Ventas, Inc. Reports Q4 Revenue $1.57B, vs. FactSet Est of $1.50B MT
06/02 (VTR) Ventas Expects Full Year 2026 Normalized FFO Range $3.78 - $3.88, vs. FactSet Est of $3.77 MT
06/02 Ventas, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
06/02 Ventas, Inc. Provides Earnings Guidance for the Full Year 2026 CI
06/02 Ventas, Inc. Declares a Quarterly Dividend, Payable in Cash on April 16, 2026 CI
21/01 Ventas announces tax treatment of 2025 distributions RE
09/01 Mizuho Securities Adjusts Ventas Price Target to $87 From $75, Maintains Outperform Rating MT
08/01 Ventas Inc - unit amends credit agreement - SEC filing RE
23/12 Ventas, Inc. acquired Fox Hollow Senior Living Community for $10.5 million. CI
22/12 BMO Capital Adjusts Price Target on Ventas to $90 From $85, Maintains Outperform Rating MT
More news

Last Transcript: Ventas, Inc.

Logo Ventas, Inc.
Ventas, Inc., Q4 2025 Earnings Call, Feb 06, 2026
06/02
More transcripts

Analysts' recommendations: Ventas, Inc.

06/02 BNP Paribas Adjusts Price Target on Ventas to $87 From $80, Maintains Outperform Rating MT
09/01 Mizuho Securities Adjusts Ventas Price Target to $87 From $75, Maintains Outperform Rating MT
22/12 BMO Capital Adjusts Price Target on Ventas to $90 From $85, Maintains Outperform Rating MT
16/12 Jefferies Adjusts Price Target on Ventas to $93 From $85, Maintains Buy Rating MT
16/12 Evercore ISI Adjusts Price Target on Ventas to $86 From $82, Maintains Outperform Rating MT
More recommendations

Press Releases: Ventas, Inc.

06/02 Ventas: Q4 Earnings Snapshot AQ
06/02 Ventas : Fourth Quarter 2025 Supplemental Report PU
06/02 Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend BU
21/01 Ventas Announces Tax Treatment of 2025 Distributions BU
15/01 Ventas Announces Fourth Quarter 2025 Earnings Release Date and Conference Call BU
More press releases

News in other languages: Ventas, Inc.

04/12 Wall Street : 191 000, ce chiffre qui sème le doute
06/25/06 Dr. Martens: Cuando las palabras valen más que los números
11/24/11 Cartera Estadounidense: Últimas compras
09/24/09 RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU.: Epam Systems, Five9, T-Mobile, Lyft, Under Armour...
07/24/07 RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK: Nvidia, The Home Depot, Palantir, Target, Lowe's, Block, Rollins...
More news

Quotes and Performance

1 day+3.39%
1 week+6.28%
Current month+6.28%
1 month+9.95%
3 months+8.52%
6 months+20.39%
Current year+6.68%
More quotes

Course Extremes

1 week 75.81
Extreme 75.81
 82.8
1 month 75.01
Extreme 75.01
 82.8
Current year 73.82
Extreme 73.82
 82.8
1 year 58.72
Extreme 58.72
 82.8
3 years 39.33
Extreme 39.33
 82.8
5 years 35.33
Extreme 35.33
 82.8
10 years 13.34
Extreme 13.345
 82.8
More quotes

Managers and Directors: Ventas, Inc.

Manager TitleAgeSince
Debra Cafaro CEO
 Chief Executive Officer 68 01/01/1999
Bob Probst DFI
 Director of Finance/CFO 58 27/10/2014
James Hutchens CIO
 Chief Investment Officer 51 23/01/2023
Director TitleAgeSince
Debra Cafaro CHM
 Chairman 68 01/01/1999
Matthew Lustig BRD
 Director/Board Member 65 12/05/2011
Melody Barnes BRD
 Director/Board Member 62 17/09/2014
More insiders

ETFs: Ventas, Inc.

Name Varia. Jan 1. Weight AuM
SYGNIA ITRIX GLOBAL PROPERTY ETF ETF Sygnia Itrix Global Property ETF
+0.76%2.26% 1,662 M€
NOMURA NEXT FUNDS INTERNATIONAL REIT S&P DEVELOPED REIT INDEX (EX JAPAN UNHEDGED) ETF - JPY ETF Nomura NEXT FUNDS International REIT S&P Developed REIT Index (ex Japan Unhedged) ETF - JPY
+5.34%1.43% 174 M€
BNP PARIBAS EASY ECPI GLOBAL ESG INFRASTRUCTURE UCITS ETF (C) - USD ETF BNP PARIBAS EASY ECPI GLOBAL ESG INFRASTRUCTURE UCITS ETF (C) - USD
-.--%0.94% 1 M€
More ETFs: Ventas, Inc.

Healthcare REITs

Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi.($)
VENTAS, INC. Stock Ventas, Inc.
+3.39%+6.28%+36.24%+59.12% 3.92TCr
WELLTOWER INC. Stock Welltower Inc.
+2.54%+4.01%+37.40%+161.23% 13TCr
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
-0.64%+3.19%+19.41%+62.00% 1.34TCr
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
+1.02%-2.26%-15.16%-36.94% 1.17TCr
AMERICAN HEALTHCARE REIT, INC. Stock American Healthcare REIT, Inc.
+1.25%+3.97%+66.45% - 868.91Cr
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+0.60%+4.02%+47.57%+93.81% 867.3Cr
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
+1.20%+0.77%+2.24%-19.12% 594.96Cr
CHARTWELL RETIREMENT RESIDENCES Stock Chartwell Retirement Residences
-0.47%+3.76%+28.48%+125.59% 477.42Cr
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
-0.78%+1.60%+14.02%+45.05% 474.51Cr
AEDIFICA SA Stock Aedifica SA
+0.61%+0.47%+26.06%-8.19% 418.48Cr
Average +0.87%+2.75%+26.27%+53.62% 2.36TCr
Weighted average by Cap. +2.11%+3.87%+33.28%+113.93%
See all sector performances

Financials

2026 *2027 *
Net sales 660.1Cr 558.77Cr 512.13Cr 485.03Cr 900.64Cr 60TCr 941.63Cr 5.95TCr 2.36TCr 29TCr 2.48TCr 2.42TCr 1,03600Cr 764.3Cr 646.98Cr 592.97Cr 561.6Cr 1.04TCr 69TCr 1.09TCr 6.89TCr 2.73TCr 33TCr 2.87TCr 2.81TCr 1,20000Cr
Net income 30Cr 26Cr 23Cr 22Cr 41Cr 2.74TCr 43Cr 272.83Cr 108.01Cr 1.32TCr 113.48Cr 111.15Cr 4.75TCr 50Cr 42Cr 39Cr 37Cr 68Cr 4.55TCr 72Cr 452.4Cr 179.1Cr 2.19TCr 188.18Cr 184.31Cr 7.88TCr
Net Debt 1.15TCr 969.52Cr 888.58Cr 841.58Cr 1.56TCr 1,03800Cr 1.63TCr 10TCr 4.09TCr 50TCr 4.3TCr 4.21TCr 1,79800Cr 1.24TCr 1.05TCr 964.11Cr 913.11Cr 1.7TCr 1,12600Cr 1.77TCr 11TCr 4.44TCr 54TCr 4.66TCr 4.56TCr 1,95100Cr
More financial data * Estimated data

Company Profile

Logo Ventas, Inc.
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2024, the Group's portfolio comprised 1,387 assets, divided between nursing homes for the elderly (835), outpatient care facilities (397) and other (155; nursing homes, long-term acute care facilities, inpatient rehabilitation facilities, etc.). Net sales are distributed geographically as follows: the United States (88.7%), Canada (10.7%) and the United Kingdom (0.6%).
Employees
498
Sector
Specialized REITs
Calendar
06/05 - Q1 2026 Earnings Release (Projected)
More about the company

Quotes

Date Price Change Volume
06/26/06 82.55 $ +3.39% 39,26,094
05/26/05 79.84 $ +2.71% 32,35,801
04/26/04 77.73 $ +0.05% 24,02,298
03/26/03 77.69 $ +0.36% 23,87,651
02/26/02 77.41 $ -0.33% 27,32,972

Delayed Quote Nyse, February 07, 2026 at 02:30 am IST

More quotes

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI
BBB
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
82.55USD
Average target price
86.85USD
Spread / Average Target
+5.21%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VTR Stock

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition